Preclinical Assessment of Low Doses of Cisplatin in the Management of Acute Promyelocytic Leukemia

Cis-diamminedichloroplatinum (II) (cisplatin) is the most widely used chemotherapeutic drug for various cancers, but its effectiveness is limited by tumor cell resistance and the severe side effects it causes. Since high level of cisplatin is cytotoxic to both cancer and normal cells, the goal of th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Cancer Res Mol Mech
Main Authors: Dasari, Shaloam R, Velma, Venkatramreddy, Yedjou, Clement G, Tchounwou, Paul B
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4758698/
https://ncbi.nlm.nih.gov/pubmed/26900603
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker